Review: home-made and commercial spacers did not differ for delivery of inhaled β2 agonists in children with asthma or wheezing
Dr C Rodriguez-Martinez, Clínica Colsánitas, Bogota, Colombia; firstname.lastname@example.org
In children with acute asthma or lower airway obstruction attacks, how do home-made and commercial spacers attached to metered-dose inhalers (MDIs) compare for delivering β2 agonists?
Studies selected compared rapid-acting β2 agonists delivered by MDIs attached to home-made spacers with MDIs attached to commercial spacers in children and adolescents <18 years of age presenting to the emergency department (ED) with acute exacerbations of wheezing or asthma. Outcomes included hospital admission, lung function (peak expiratory flow rate [PEFR], oxygen saturation, and respiratory rate), heart rate, clinical score, intensive care unit (ICU) admission, …